Pharmaceutical Equivalence Drugs Assessment-I (PEDA-I): Assess the pharmaceutical equivalence of generic antiretrovirals distributed in Thailand

Project no.: HIV-NAT 201/PEDA-1

This study will assess the pharmaceutical equivalence of generic antiretroviral drugs (i.e., TDF, EFV and LPV/r) distributed from different sources in Thailand. Our goal is to ensure that they are within acceptable standard regarding identity, active ingredient, weight uniformity and dissolution properties. We plan to set up a system for independent drug assessment program, which could be expanded beyond ARVs for the country.